Orexin a phosphorylates the γ-Aminobutyric acid type A receptor β2 subunit on a serine residue and changes the surface expression of the receptor in SH-SY5Y cells exposed to propofol

J Neurosci Res. 2015 Nov;93(11):1748-55. doi: 10.1002/jnr.23631. Epub 2015 Aug 18.

Abstract

Propofol activates the γ-aminobutyric acid type A receptor (GABAA R) and causes a reversible neurite retraction, leaving a thin, thread-like structure behind; it also reverses the transport of vesicles in rat cortical neurons. The awakening peptide orexin A (OA) inhibits this retraction via phospholipase D (PLD) and protein kinase Cɛ (PKCɛ). The human SH-SY5Y cells express both GABAA Rs and orexin 1 and 2 receptors. These cells are used to examine the interaction between OA and the GABAA R. The effects of OA are studied with flow cytometry and immunoblotting. This study shows that OA stimulates phosphorylation on the serine residues of the GABAA R β2 subunit and that the phosphorylation is caused by the activation of PLD and PKCɛ. OA administration followed by propofol reduces the cell surface expression of the GABAA R, whereas propofol stimulation before OA increases the surface expression. The GABAA R β2 subunit is important for receptor recirculation, and the effect of OA on propofol-stimulated cells may be due to a disturbed recirculation of the GABAA R.

Keywords: AB_10675844; AB_10712311; AB_1269637; AB_1566589; AB_2247467; AB_307184; AB_307187; GABAAR; cell signaling; orexin; propofol.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthetics, Intravenous / pharmacology*
  • Cell Line, Tumor
  • Flow Cytometry
  • Humans
  • Immunoblotting
  • Neurons / drug effects*
  • Neurons / metabolism
  • Orexins / metabolism*
  • Phosphorylation
  • Propofol / pharmacology*
  • Receptors, GABA-A / drug effects
  • Receptors, GABA-A / metabolism*
  • Serine / metabolism

Substances

  • Anesthetics, Intravenous
  • Orexins
  • Receptors, GABA-A
  • Serine
  • Propofol